期刊文献+

IL-6、PHA联合磁珠分选对CIK增殖能力和杀伤肾癌786-O细胞功能的影响 被引量:1

The effect of IL-6、PHA and IMB sorting on proliferation and function of CIK cells
下载PDF
导出
摘要 目的通过体外实验研究白介素-6(IL-6)、植物血凝素(PHA)联合免疫磁珠(IMB)分选对CIK增殖能力和杀伤肾癌786-O细胞功能的影响,为肾脏肿瘤的免疫治疗提供理论依据。方法分离肿瘤患者外周血单个核细胞(PBMC),经Mini MACS免疫磁珠去除CD4+CD25+Treg细胞后分为4组:对照组以CD3 Mc Ab、IL-2和IFN-γ诱导培养;PHA-CIK组、IL-6-CIK分别在对照组的基础上加用PHA、IL-6;PHA-IL-6-CIK组在对照组的基础上加用PHA和IL-6。CCK-8法检测各组CIK细胞的增殖率;流式细胞术(FCM)检测各组CIK细胞CD3+CD8+、CD3+CD56+、Treg表型比例;乳酸脱氢酶(LDH)释放法检测各组CIK细胞对肾癌786-O细胞的杀伤功能。结果磁珠分选后,PBMC中Treg细胞的比例降低至(1.21±0.53)%;PHA-IL-6-CIK组细胞的增殖率达(28.33±3.05)%;PHA-IL-6-CIK组细胞的CD3+CD8+、CD3+CD56+比例分别升高至(63.13±2.70)%和(35.32±2.96)%,Treg细胞比例降低至(1.11±0.07)%;在效靶比为30:1时,PHA-IL-6-CIK组细胞对肾癌786-O细胞的杀伤率可达(42.76±3.40)%。结论 IL-6、PHA联合磁珠分选可显著增强CIK的增殖和杀伤肾癌786-O细胞能力。 Objective To observe the effects of IL-6,PHA and IMB sorting on the proliferation of cytokine induced killer( CIK) cells and the killing activity of CIK cells on renal cancer cells 786-O in vitro,and provide important theoretical basis for renal cancer immunotherapy. Methods Peripheral blood mononuclear cells( PBMC) were isolated from the patients,CD4+CD25+Treg cells were removed with Mini MACS immunomagnetic bead( IMB) sorting. PBMC were divided into control group( cells were cultured in presence of CD3 Mc Ab,IL-2,IFN-γ),PHA-CIK group( cells were cultured in presence of CD3 Mc Ab,IL-2,IFN-γ and PHA),IL-6-CIK group( cells were cultured in presence of CD3 Mc Ab,IL-2,IFN-γand IL-6) and PHA-IL-6-CIK group( cells were cultured in presence of CD3 Mc Ab,IL-2,IFN-γ,PHA and IL-6). The proliferation rate of CIK cells of each group was assayed by Cell Counting Kit-8; flow cytometry( FCM) was used to detect the proportion of phenotypes( including CD3+CD8+,CD3+CD56+,Treg cells). Lactate dehydrogenase( LDH) release assay was used to measure cytotoxicity of CIK cells of each group against renal cancer cell 786-O. Results After IMB sorting,the proportion of Treg cells in PBMC decreased to( 1. 21 ± 0. 53) %; the proliferation rate of PHA-IL-6-CIK cells was up to( 28. 33 ± 3. 05) %; the proportion of CD3+CD8+and CD3+CD56+increased to( 63. 13 ± 2. 70) % and( 35. 32 ±2. 96) %; the proportion of Treg cells decreased to( 1. 11 ± 0. 07) %; target ratio of 30∶ 1,and the killing rate of PHA-IL-6-CIK cells to renal cancer cells 786-O was up to( 42. 76 ± 3. 40) %. Conclusion IL-6,PHA and IMB sorting could increase the proliferation of CIK cells and the killing activity of CIK cells on renal cancer cells in vitro significantly.
出处 《中国输血杂志》 CAS 北大核心 2016年第4期372-376,共5页 Chinese Journal of Blood Transfusion
基金 江苏省高校自然科学基金(11KJB320017) 国家自然科学基金(81372916)
关键词 CIK PHA IL-6 IMB Treg 肾癌 CIK phytohaemagglutinin IL-6 IMB immunotherapy renal cance
  • 相关文献

参考文献22

  • 1Schmidt-Wolf IG, Negrin RS, Kiem HP, et al. Use of a SCID mouse/human lymphoma model to evaluate cytokine-inducod killer cells with potent antitumor cell activity. J Exp Med, 1991, 174 ( 1 ) : 139-149.
  • 2Pievani A, Borleri G, Pende D, et al. Dual-functional capability of CD3 CD56 + CIK cells, a T-cell subset that acquires NK func- tion and retains TCR-mediatod specific cytotoxicity. Blood, 2011, 118(12) : 3301-3310.
  • 3Baumgartuer P, Raemaekers ILl, Durieux A, et al. Large-seale production, purification, and characterisation of recombinant Phaseolus vulgaris phytohemagglutinin E-form expressed in the methylotrophic yeast Pichia pastoris. Protein Expr Purif, 2002, 26 (3) : 394-405.
  • 4Whiteside TL. What are regulatory T cells (Treg) regulating in cancer and why? Semin Cancer Biol, 2012, 22(4) : 327-334.
  • 5Burchill MA, Yang J, Vogtenhuber C, et al. IL-2 receptor beta- dependent STATS activation is required for the development of Foxp3 * regulatory T cells. J Immunol, 2007, 178 ( 1 ) : 280-290.
  • 6Barthlott T, Moncrleffe H, Veldhoen M, et al. CD25+ CIM+ T cells compete with naive CIM + T cells for IL-2 and exploit it for the induction of 1L-10 production. Int Immunol, 2005, 17 ( 3 ) : 279-288.
  • 7Bettelli E, Carrier Y, Gao W, et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regu- latory T calla. Nature, 2006, 441 (7090) : 235-238.
  • 8Mohta BA, Schmidt-Wolf IG, Weissman IL, et al. Two pathways of exocytosis of cytoplasmic granule contents and target cell killing by ytokine-induced CD3 + CD56 + killer cells. Blood, 1995, 86(9) : 3493-3499.
  • 9Linn YC, Wang SM, Hui KM. Comparative gene expression profi- ling of cytokine-induced killer cells in response to acute myloid leukemic and acute lymphoblastic leukemic stimulators using oligo- nudeotide arrays. Exp Hematol, 2005, 33(6): 671-681.
  • 10Vernefis MR, Komacker M, Mailander V, et al. Resistance of ex vivo expanded CD3 + CD56 + T ceils to Fas-mediated apoptosis. Cancer Immunol Immunother, 2000, 49: 335-345.

二级参考文献6

  • 1Schmidt RE, Murray C, Daley JF, et al. A subset of natural killer cells in peripheral blood displays a mature T cell phenotype. J Exp Med, 1986; 164:351-357
  • 2Lanier LL, Le AM, Civin CI, et al. The relationship of CD16 (Leu-11) and leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes. J Immunol,1986; 136:4480 - 4488
  • 3Ortaldo JR, Winkler-Pickett RT, Yagita H, et al. Comparative studies of CD3+ and CD3+ CD56+ cells: examination of morphology, functions, T cell receptor rearrangement, and pore-forming protein expression. Cell Immunol, 1991; 136: 486 - 495
  • 4Gritzapis AD, Dimitroulopoulos D, Paraskevas E, et al. Largescale expansion of CD3( + )CD56 ( + ) lymphocytes capable of lysing autologous tumor cells with cytokine-rich supernatants. Cancer Immunol Immunother, 2002; 51:440-448
  • 5Zoll B, Lefterova P, Csipai M, et al. Generation of cytokine-induced killer cells using exogenous interleukin-2, -7 or -12. Cancer Immunol Immunother, 1998; 47; 221- 226
  • 6袁小林,程一棹,王艳,郭连英,钱振超.PHA-LAK细胞激活培养过程中多项免疫学指标的动态分析[J].上海免疫学杂志,1997,17(4):204-207. 被引量:9

共引文献2

同被引文献3

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部